| ATC Code | R05DB13 |
| CAS number | 18109-80-3 |
| PUB number | 28892 |
| Drugbank ID | DB13731 |
| Empirical formula | C18H29NO3 |
| Molar mass (g·mol−1) | 307,434 |
| Physical state | solid |
| PKS value | 9,41 |
Butamirate is a cough-suppressing drug used orally to treat irritable cough. Unlike codeine, it is not related to the opioids.
Es wird in Sirup-, Tropfen- oder Tablettenform verabreicht.
Wegen der zentral dämpfenden Wirkungen wird es häufig als Rauschmittel missbraucht.
Binding to receptors in the cough center in the medulla oblongata in the brain inhibits the cough stimulus and relaxes bronchial muscles.
Butamirate has a half-life of 1-2 hours.
Interactions with butamirate may occur with concomitant use with expectorants, central depressant drugs, and alcohol.
Adverse side effects include:
Markus Falkenstätter, BSc
Mag. pharm. Stefanie Lehenauer
Browse our extensive database of medications from A-Z, including effects, side effects, and dosage.
All active ingredients with their effects, applications, and side effects, as well as the medications they are contained in.
Symptoms, causes, and treatments for common diseases and injuries.
The presented content does not replace the original package insert of the medication, especially regarding the dosage and effects of individual products. We cannot assume liability for the accuracy of the data, as the data has been partially converted automatically. Always consult a doctor for diagnoses and other health-related questions.
© medikamio